Literature DB >> 810310

The bioavailability of ultramicrosize griseofulvin (Gris-PEG) tablets in man.

W E Barrett, J R Bianchine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 810310

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  5 in total

Review 1.  Nonlinear pharmacokinetics: clinical Implications.

Authors:  T M Ludden
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

2.  Development of anti-influenza virus drugs I: improvement of oral absorption and in vivo anti-influenza activity of Stachyflin and its derivatives.

Authors:  S Yagi; J Ono; J Yoshimoto; K Sugita; N Hattori; T Fujioka; T Fujiwara; H Sugimoto; K Hirano; N Hashimoto
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

3.  Bioavailability of microsize and ultramicrosize griseofulvin products in man.

Authors:  A B Straughn; M C Meyer; G Raghow; K Rotenberg
Journal:  J Pharmacokinet Biopharm       Date:  1980-08

4.  Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.

Authors:  M Schäfer-Korting; H C Korting; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

5.  Human plasma and skin blister fluid levels of griseofulvin after its repeated administration.

Authors:  M Schäfer-Korting; H C Korting; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.